Arthur Peter Bertolino - Net Worth and Insider Trading
Arthur Peter Bertolino Net Worth
The estimated net worth of Arthur Peter Bertolino is at least $115,603 dollars as of 2024-04-29. Arthur Peter Bertolino is the EVP and Chief Medical Officer of Revance Therapeutics Inc and owns about 34,001 shares of Revance Therapeutics Inc (RVNC) stock worth over $115,603. Details can be seen in Arthur Peter Bertolino's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Arthur Peter Bertolino has not made any transactions after 2015-11-17 and currently still holds the listed stock(s).
Transaction Summary of Arthur Peter Bertolino
Arthur Peter Bertolino Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Arthur Peter Bertolino owns 2 companies in total, including Innovation Pharmaceuticals Inc (IPIX) , and Revance Therapeutics Inc (RVNC) .
Click here to see the complete history of Arthur Peter Bertolino’s form 4 insider trades.
Insider Ownership Summary of Arthur Peter Bertolino
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| IPIX | Innovation Pharmaceuticals Inc | 2017-09-01 | Pres. & Chief Medical Officer |
| RVNC | Revance Therapeutics Inc | 2015-11-17 | EVP and Chief Medical Officer |
Arthur Peter Bertolino Latest Holdings Summary
Arthur Peter Bertolino currently owns a total of 1 stock. Arthur Peter Bertolino owns 34,001 shares of Revance Therapeutics Inc (RVNC) as of November 17, 2015, with a value of $115,603.
Latest Holdings of Arthur Peter Bertolino
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| RVNC | Revance Therapeutics Inc | 2015-11-17 | 34,001 | 3.40 | 115,603 |
Holding Weightings of Arthur Peter Bertolino
Arthur Peter Bertolino Form 4 Trading Tracker
According to the SEC Form 4 filings, Arthur Peter Bertolino has made a total of 0 transactions in Revance Therapeutics Inc (RVNC) over the past 5 years. The most-recent trade in Revance Therapeutics Inc is the sale of 7,753 shares on November 17, 2015, which brought Arthur Peter Bertolino around $303,220.
Insider Trading History of Arthur Peter Bertolino
- 1
Arthur Peter Bertolino Trading Performance
Arthur Peter Bertolino Ownership Network
Ownership Network List of Arthur Peter Bertolino
Ownership Network Relation of Arthur Peter Bertolino
Arthur Peter Bertolino Owned Company Details
What does Innovation Pharmaceuticals Inc do?
Who are the key executives at Innovation Pharmaceuticals Inc?
Arthur Peter Bertolino is the Pres. & Chief Medical Officer of Innovation Pharmaceuticals Inc. Other key executives at Innovation Pharmaceuticals Inc include Vice President Jane A. Harness , director & 10 percent owner & Chief Financial Officer Leo Ehrlich , and director & 10 percent owner & President-Chief Scient.Officer Krishna Menon .
Innovation Pharmaceuticals Inc (IPIX) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Innovation Pharmaceuticals Inc (IPIX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Innovation Pharmaceuticals Inc (IPIX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Innovation Pharmaceuticals Inc (IPIX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Innovation Pharmaceuticals Inc Insider Transactions
Arthur Peter Bertolino Mailing Address
Above is the net worth, insider trading, and ownership report for Arthur Peter Bertolino. You might contact Arthur Peter Bertolino via mailing address: C/o Innovation Pharmaceuticals Inc., 100 Cummings Center, Suite 151-b, Beverly Ma 01915.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
